The Miami Entrepreneur

Bristol Myers Squibb results top estimates as new drugs post strong sales growth 

Read Time:5 Second

Bristol Myers Squibb also issued its full-year 2024 forecast, which was generally in line with expectations.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Exxon beats earnings expectations even as lower oil prices weigh on profits
Next post Exxon Mobil’s stock rallies after profit and free cash flow beat expectations, while revenue fell well short